Cargando…
Blood Arsenic Levels as a Marker of Breast Cancer Risk among BRCA1 Carriers
SIMPLE SUMMARY: Arsenic (As) is recognized by the International Agency for Research on Cancer (IARC) as a potent carcinogen. Numerous studies are focused on endemic regions of high exposure, and its effect on human health. Several authors suggest that As may be an important endocrine disruptor, main...
Autores principales: | Marciniak, Wojciech, Matoušek, Tomáš, Domchek, Susan, Paradiso, Angelo, Patruno, Margherita, Irmejs, Arvids, Roderte, Irita, Derkacz, Róża, Baszuk, Piotr, Kuświk, Magdalena, Cybulski, Cezary, Huzarski, Tomasz, Gronwald, Jacek, Dębniak, Tadeusz, Falco, Michał, Lener, Marcin R., Jakubowska, Anna, Pullella, Katherine, Kotsopoulos, Joanne, Narod, Steven, Lubiński, Jan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8269342/ https://www.ncbi.nlm.nih.gov/pubmed/34283078 http://dx.doi.org/10.3390/cancers13133345 |
Ejemplares similares
-
Blood arsenic levels and the risk of familial breast cancer in Poland
por: Marciniak, Wojciech, et al.
Publicado: (2019) -
Serum Selenium Level Predicts 10-Year Survival after Breast Cancer
por: Szwiec, Marek, et al.
Publicado: (2021) -
Serum Essential Elements and Survival after Cancer Diagnosis
por: Lubiński, Jan, et al.
Publicado: (2023) -
Blood Copper Levels and the Occurrence of Colorectal Cancer in Poland
por: Baszuk, Piotr, et al.
Publicado: (2021) -
Risk of Second Primary Thyroid Cancer in Women with Breast Cancer
por: Cieszyńska, Monika, et al.
Publicado: (2022)